182 related articles for article (PubMed ID: 16718947)
1. Probable interaction between tolterodine and warfarin.
Taylor JR
Pharmacotherapy; 2006 May; 26(5):719-21. PubMed ID: 16718947
[TBL] [Abstract][Full Text] [Related]
2. Tolterodine-warfarin drug interaction.
Colucci VJ; Rivey MP
Ann Pharmacother; 1999 Nov; 33(11):1173-6. PubMed ID: 10573314
[TBL] [Abstract][Full Text] [Related]
3. Hallucinations with tolterodine.
Williams SG; Staudenmeier J
Psychiatr Serv; 2004 Nov; 55(11):1318-9. PubMed ID: 15534031
[No Abstract] [Full Text] [Related]
4. Re: safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
Schaefer W
J Urol; 2006 Nov; 176(5):2311-2; author reply 2312-3. PubMed ID: 17070326
[No Abstract] [Full Text] [Related]
5. Tolterodine.
Nurs Times; 2006 Jun 6-12; 102(23):27. PubMed ID: 16784047
[No Abstract] [Full Text] [Related]
6. Tolterodine once-daily in treatment of the overactive bladder.
Peters KM; Huang RR
Urology; 2001 Nov; 58(5):829-32. PubMed ID: 11711378
[No Abstract] [Full Text] [Related]
7. Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder.
Armstrong RB; Luber KM; Peters KM
Int Urol Nephrol; 2005; 37(2):247-52. PubMed ID: 16142551
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of tolterodine for the treatment of overactive bladder in adults.
Roberts RG; Garely AD; Bavendam T
Am J Manag Care; 2005 Jul; 11(4 Suppl):S158-62. PubMed ID: 16161389
[TBL] [Abstract][Full Text] [Related]
9. A potential interaction between warfarin and atovaquone.
Hidalgo K; Lyles A; Dean SR
Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
[TBL] [Abstract][Full Text] [Related]
10. Clinical experiences with tolterodine.
Nilvebrant L
Life Sci; 2001 Apr; 68(22-23):2549-56. PubMed ID: 11392625
[TBL] [Abstract][Full Text] [Related]
11. Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors.
Edwards KR; O'Connor JT
J Am Geriatr Soc; 2002 Jun; 50(6):1165-6. PubMed ID: 12110086
[No Abstract] [Full Text] [Related]
12. Comparison of tolterodine with standard treatment in pediatric patients with non-neurogenic dysfunctional voiding/over active bladder: a systematic review.
Medhi B; Mittal N; Bansal D; Prakash A; Sarangi SC; Nirthi B
Indian J Physiol Pharmacol; 2013; 57(4):343-53. PubMed ID: 24968572
[TBL] [Abstract][Full Text] [Related]
13. Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.
Gacci M; Novara G; De Nunzio C; Tubaro A; Schiavina R; Brunocilla E; Sebastianelli A; Salvi M; Oelke M; Gravas S; Carini M; Serni S
BMC Urol; 2014 Oct; 14():84. PubMed ID: 25348235
[TBL] [Abstract][Full Text] [Related]
14. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers.
Rahimy M; Hallén B; Narang P
Arzneimittelforschung; 2002; 52(12):890-5. PubMed ID: 12572529
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study.
Agarwal A; Dhiraaj S; Singhal V; Kapoor R; Tandon M
Br J Anaesth; 2006 Mar; 96(3):377-80. PubMed ID: 16415311
[TBL] [Abstract][Full Text] [Related]
16. [Comparisons of efficacy and safety of tolterodine and oxybutynin in children with idiopathic overactive bladder].
Deng YJ; Ma G; Guo YF; Ge Z; Lu RG; Wang LX; Zhu HB; Chen CJ
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Jan; 13(1):26-8. PubMed ID: 21251382
[TBL] [Abstract][Full Text] [Related]
17. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder.
Abrams P; Freeman R; Anderström C; Mattiasson A
Br J Urol; 1998 Jun; 81(6):801-10. PubMed ID: 9666761
[TBL] [Abstract][Full Text] [Related]
18. Benefit-risk assessment of tolterodine in the treatment of overactive bladder in adults.
Garely AD; Burrows L
Drug Saf; 2004; 27(13):1043-57. PubMed ID: 15471509
[TBL] [Abstract][Full Text] [Related]
19. Tolterodine immediate release improves sexual function in women with overactive bladder.
Hajebrahimi S; Azaripour A; Sadeghi-Bazargani H
J Sex Med; 2008 Dec; 5(12):2880-5. PubMed ID: 18785896
[TBL] [Abstract][Full Text] [Related]
20. The newer antimuscarinic drugs: bladder control with less dry mouth.
Appell RA
Cleve Clin J Med; 2002 Oct; 69(10):761, 765-6, 768-9. PubMed ID: 12371799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
